The field of chemotherapy is very active. The National Cancer Institute (NCI) and the pharmaceutical industry are always searching for promising new chemotherapies.
Six to ten new drugs are introduced each year. Most
are modifications of previously known drugs (analogues)
or new formulations of old drugs. A number of new
compounds also enter trial each year, but many are
found early in their development to have problems
or to share mechanisms of action or resistance with